Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Denfivontinib by Genosco for Solid Tumor: Likelihood of Approval
Denfivontinib is under clinical development by Genosco and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
Denfivontinib by Genosco for Refractory Acute Myeloid Leukemia: Likelihood of Approval
Denfivontinib is under clinical development by Genosco and currently in Phase I for Refractory Acute Myeloid Leukemia. According to GlobalData,...
Denfivontinib by Genosco for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
Denfivontinib is under clinical development by Genosco and currently in Phase I for Relapsed Acute Myeloid Leukemia. According to GlobalData,...